Melanotan-2 Appetite Suppression Research Mechanisms A 2018 study published in the Journal of Clinical Investigation found that synthetic melanocortin receptor agonists reduced ad libitum food intake by 2228% in human subjects over a 14-day observation period
Song, M., Liu, G., Liu, Y., Cheng, Z., Lin, H., Liu, J., et al., Eur
People currently on GLP-1 medications who want gut support
Furthermore, the amylin and GLP-1 analogs salmon calcitonin (sCT) and liraglutide produce synergistic-like reductions in 24 hours energy intake and body weight
Proper refrigeration extends this window but cannot match lyophilized stability
GuimaresCAhmedRMarquesAReisRDemirciU